Watertown, MA, United States of America

Solymar Negretti-Emmanuelli

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 6.4

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Solymar Negretti-Emmanuelli: Innovator in Pharmaceutical Science

Introduction

Solymar Negretti-Emmanuelli is a notable inventor based in Watertown, MA (US). He has made significant contributions to the field of pharmaceutical science, particularly in the development of compounds that target viral infections. With a total of five patents to his name, his work is recognized for its potential impact on public health.

Latest Patents

One of Solymar's latest patents involves benzodiazepine derivatives as inhibitors of Respiratory Syncytial Virus (RSV). The invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof, which inhibit RSV. This patent further relates to pharmaceutical compositions comprising these compounds for administration to subjects suffering from RSV infection. Additionally, it outlines methods for treating RSV infections by administering the pharmaceutical compositions developed in this invention.

Career Highlights

Solymar is currently associated with Enanta Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on developing effective treatments for viral infections, showcasing his commitment to advancing medical science.

Collaborations

Throughout his career, Solymar has collaborated with esteemed colleagues, including Jianming Yu and In Jong Kim. These partnerships have contributed to the success of his research and the development of his patented inventions.

Conclusion

Solymar Negretti-Emmanuelli stands out as a dedicated inventor in the pharmaceutical industry, with a focus on combating viral infections through innovative compounds. His contributions are vital to the ongoing efforts in medical research and treatment development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…